Government Planning New Political Circulation By Pharmaceutical Tender Shall Not Be?

February 4, the reporter was informed from the source for parts Drugs Tender Irregularities, the government department is planning to introduce "medical institutions centralized drug procurement specification (draft)", to regulate the bidding of drugs.



Associations of a person confirmed to reporters the news, on February 1 at noon Association received fax, consult the views of the drug tender. Return time to be very tight, Feb. 2 pm to be handed over.



Not cut circulation? In the drug tender areas, the distribution companies are the most affected part.



Order to reduce the circulation and reduce drug prices, the Ministry of Health in January 2009 issued a "Further specification of the Drug centralized purchasing of medical opinion" to provide centralized procurement of drugs by the wholesale companies to bid directly from the drug manufacturer tender, commissioned by the manufacturer or the ability of modern pharmaceutical logistics enterprises to direct distribution of medical institutions, in principle, allow the commission only once.



"With a drug, the same distribution channels, why pharmacies cheaper than the hospital?" Marketing Experts Geng Hongwu of the "Daily Economic News", told reporters that the reasons for high drug prices are not too many in circulation.



The same time, reporters covering the drug manufacturers found that the direct distribution of their drugs are not very positive.



Tender of a pharmaceutical company manager, told reporters that direct delivery from the manufacturer's ideas are not realistic, distribution companies must be established to conduct meet the requirements of modern logistics such as storage and transportation conditions, which requires strong financial strength , together with manufacturers of drugs themselves can only distribution, so they do not intend to self logistics, or the commissioned distributor.



Direct bid for the producers, he said, if the Medicine Commercial companies should be marked, they can reduce the cost of more than half. If each province had to be the subject of the tender, they must pay a considerable human, material and financial resources.



There are two drawbacks of the tender



In addition, the ability to select drugs with modern logistics enterprises, in the provinces is also on the winning tender was selected distribution companies, from a dozen to several hundred range. This means that not short-listed pharmaceutical companies will lose the right distribution. This is considered a national pharmaceutical distribution industry to improve the degree of concentration of a big move.



, However, who asked not to be named president of pharmaceutical business our business on the "Daily Economic News", told reporters that a pattern of distribution and secondary distribution, once or several times by the market mechanism, and the commission, the administrative intervention would not only increase the degree of concentration, but concentration will decrease.



Case of Fujian, Fujian has 40 qualified distributor, responsible for each distribution area are not the same, at least in one area pharmaceutical companies choosing a distributor, so that each manufacturer will face more distribution business, size and number of shipments will substantially lower than the directly contracted to a level distribution business. Now the implementation of direct distribution and a delegate, would make the industry more scattered, and does not help pharmaceutical companies reduce costs.



Another pharmaceutical business, told reporters the company is reflected in the tender manager should be more rights to the hospital. Distribution after the selection of government enterprises, pharmaceutical companies generally only choose a ~ 3, which virtually reduced the hospital's right to choose.



Shanghai Haihong Pharmaceutical Marketing Manager this e Yang Changshun on the "Daily Economic News" reporter said that at present there are two drawbacks pharmaceutical tender.



Pricing of essential medicines in the Development and Reform Commission, based on the provinces is still strong bargain. Low drug prices has resulted in harm to the drug industry, a number of excellent products because the price is too low, before the end of the life cycle.



In addition, drug prices will not re-tender and the quality of the phenomenon persists. At present, the tender has yet to find an effective quality assessment mechanisms, have not taken out of CD value is the cycle.

About the Author:
I am China Manufacturers writer, reports some information about goldstar appliances , am fm cd boombox.

Author: hotxueboy
-